Private equity firm acquires orthopedic technology company: 4 things to know

Written by Laura Dyrda | December 31, 2018 | Print  |

Chicago-based healthcare private equity firm Linden Capital Partners completed the acquisition of Avalign Technologies, a Bannockburn, Ill.-based provider of implants, specialty surgical instruments, cutting tools and cases and trays for orthopedics and acute care, according to PE Hub.

Here are four things to know:

1. Financial terms of the agreement weren't disclosed.

2. Avalign has a broad portfolio of manufacturing solutions and can bring new ideas from concept to launch. "We are proud of the business we have built at Avalign and are excited to partner with Linden through our next phase of growth," said Avalign CEO Forrest Whittaker. "We chose Linden because of their deep healthcare and contract manufacturing expertise and are confident they have the experience and resources to support the company's growth strategy."

3. Avalign has a reputation for quality systems, flexible capacity capabilities and customer service. "We are excited to partner with the management team to continue to pursue the company's value creation plan," said Linden Operating Partner and Chairman of Avalign Technologies Ernest Waaser.

4. Kirkland & Ellis was the legal advisor to Linden and William Blair & Company and Harris Williams were financial advisors to Avalign.

More articles on orthopedic devices:
Spine device company withdraws $17M IPO: 4 key notes
Orthopedic medical robots market to hit $2.1B by 2025: 4 notes
Medtronic finalizes $1.7B Mazor acquisition—5 key notes on what to expect next

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months